{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:59:04Z","timestamp":1762505944023,"version":"build-2065373602"},"reference-count":29,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2012,7,3]],"date-time":"2012-07-03T00:00:00Z","timestamp":1341273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2013,5]]},"abstract":"<jats:sec>\n                    <jats:title>What's known on the subject? and What does the study add?<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            Upper tract urothelial carcinoma (\n                            <jats:styled-content style=\"fixed-case\">UTUC<\/jats:styled-content>\n                            ) is relatively uncommon, accounting for only \u223c5% of urothelial malignancies and 10% of all renal tumours. Radical nephroureterectomy (\n                            <jats:styled-content style=\"fixed-case\">RNU<\/jats:styled-content>\n                            ) with bladder cuff excision is the surgical standard of care for treating localized\n                            <jats:styled-content style=\"fixed-case\">UTUC<\/jats:styled-content>\n                            , but the prognosis for patients who undergo\n                            <jats:styled-content style=\"fixed-case\">RNU<\/jats:styled-content>\n                            remains poor. Evidence suggests that an interactive relationship exists between haemostatic factors and tumour biology. A number of procoagulant and fibrinolytic factors have been found to be overexpressed in tumours. One of these factors is plasma fibrinogen. Recent studies have shown that elevated pre\u2010therapeutic plasma fibrinogen levels are associated with worse outcome in various malignancies; however, the prognostic value of plasma fibrinogen levels for\n                            <jats:styled-content style=\"fixed-case\">UTUC<\/jats:styled-content>\n                            has not yet been reported.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            To the best of our knowledge, this is the first paper to evaluate the prognostic impact of preoperative plasma fibrinogen levels in patients with localized\n                            <jats:styled-content style=\"fixed-case\">UTUC<\/jats:styled-content>\n                            treated surgically. We believe that the present results may assist in decision\u2010making with respect to the need for lymph node dissection and neoadjuvant chemotherapy.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            To investigate the prognostic value of plasma fibrinogen levels as a predictor of patient outcome in upper tract urothelial carcinoma (\n                            <jats:styled-content style=\"fixed-case\">UTUC<\/jats:styled-content>\n                            ).\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            A total of 218 patients who underwent radical nephroureterectomy (\n                            <jats:styled-content style=\"fixed-case\">RNU<\/jats:styled-content>\n                            ) for localized\n                            <jats:styled-content style=\"fixed-case\">UTUC<\/jats:styled-content>\n                            (\n                            <jats:styled-content style=\"fixed-case\">pTa<\/jats:styled-content>\n                            \u2010\n                            <jats:styled-content style=\"fixed-case\">4N0M0<\/jats:styled-content>\n                            ) were identified between 1995 and 2009.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>The association between preoperative plasma fibrinogen levels and clinicopathological variables was analysed.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            Forty\u2010five patients experienced tumour recurrence, and 36 died from disease during the mean follow\u2010up of 51 months. The mean (\n                            <jats:sc>sd<\/jats:sc>\n                            ) preoperative plasma fibrinogen level was 362 (103) mg\/d\n                            <jats:styled-content style=\"fixed-case\">L<\/jats:styled-content>\n                            .\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            Kaplan\u2013Meier curves showed that subsequent tumour recurrence was strongly predicted in patients with preoperative plasma fibrinogen levels \u2265450\u2009mg\/d\n                            <jats:styled-content style=\"fixed-case\">L<\/jats:styled-content>\n                            , and similar results were observed for cancer\u2010specific survival.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            On multivariate analysis we found that a preoperative plasma fibrinogen level of \u2265450\u2009mg\/d\n                            <jats:styled-content style=\"fixed-case\">L<\/jats:styled-content>\n                            was an independent risk factor for subsequent tumour recurrence and cancer\u2010specific survival.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            The 5\u2010year recurrence\u2010free survival rate was 56.9% in patients with plasma fibrinogen levels \u2265450\u2009mg\/d\n                            <jats:styled-content style=\"fixed-case\">L<\/jats:styled-content>\n                            and 81.5% in patients with plasma fibrinogen levels &lt;450\u2009mg\/dL (\n                            <jats:italic>P<\/jats:italic>\n                            &lt; 0.001). The 5\u2010year cancer\u2010specific survival rate was 59.5% in patients with plasma fibrinogen levels of \u2265450\u2009mg\/d\n                            <jats:styled-content style=\"fixed-case\">L<\/jats:styled-content>\n                            and 84.8% in patients with plasma fibrinogen levels &lt;450\u2009mg\/dL (\n                            <jats:italic>P<\/jats:italic>\n                            &lt; 0.001).\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            On multivariate analysis, controlling for preoperative indicators, a preoperative plasma fibrinogen level of \u2265450\u2009mg\/d\n                            <jats:styled-content style=\"fixed-case\">L<\/jats:styled-content>\n                            predicted worse pathological features, such as \u2265\n                            <jats:styled-content style=\"fixed-case\">pT<\/jats:styled-content>\n                            3 disease and positive lymphovascular invasion, in surgical specimens.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            Preoperative elevated plasma fibrinogen level was an independent predictor for poor survival after\n                            <jats:styled-content style=\"fixed-case\">RNU<\/jats:styled-content>\n                            and for worse pathological features.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Plasma fibrinogen levels may become a useful biomarker, particularly because of its low associated cost and easy accessibility.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1464-410x.2012.11353.x","type":"journal-article","created":{"date-parts":[[2012,7,3]],"date-time":"2012-07-03T10:35:04Z","timestamp":1341311704000},"page":"857-864","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Prognostic value of plasma fibrinogen levels in patients with localized upper tract urothelial carcinoma"],"prefix":"10.1111","volume":"111","author":[{"given":"Nobuyuki","family":"Tanaka","sequence":"first","affiliation":[{"name":"Department of Urology Keio University School of Medicine  Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Department of Urology Keio University School of Medicine  Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Urology Keio University School of Medicine  Japan"},{"name":"Department of Urology Saiseikai Central Hospital  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozomi","family":"Hayakawa","sequence":"additional","affiliation":[{"name":"Department of Urology Keio University School of Medicine  Japan"},{"name":"Department of Urology Saiseikai Central Hospital  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Ide","sequence":"additional","affiliation":[{"name":"Department of Urology Keio University School of Medicine  Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Miyajima","sequence":"additional","affiliation":[{"name":"Department of Urology Keio University School of Medicine  Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"So","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Urology Saiseikai Central Hospital  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mototsugu","family":"Oya","sequence":"additional","affiliation":[{"name":"Department of Urology Keio University School of Medicine  Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,7,3]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2010.12.042"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2005.03.011"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2008.01.006"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24135"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(98)00295-7"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2010.07.003"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature01322"},{"key":"e_1_2_8_9_1","first-page":"455","article-title":"Fibrinogen influx and accumulation of cross\u2010linked fibrin in healing wounds and in tumor stroma","volume":"130","author":"Brown LF","year":"1988","journal-title":"Am J Pathol"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s000180050497"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2009-0079"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605547"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1159\/000205234"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.10.3302"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.46.27865"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02808.x"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH04-01-0024"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.15.1225"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01307180"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-06-2272"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.17.2361"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2009.11.035"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.05.011"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26172"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2010.06.029"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022148"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2008.04.032"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)65273-X"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(03)00026-8"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.03.030"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1464-410X.2012.11353.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1464-410X.2012.11353.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:37:22Z","timestamp":1761748642000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/j.1464-410X.2012.11353.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,3]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["10.1111\/j.1464-410X.2012.11353.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1464-410x.2012.11353.x","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"type":"print","value":"1464-4096"},{"type":"electronic","value":"1464-410X"}],"subject":[],"published":{"date-parts":[[2012,7,3]]},"assertion":[{"value":"2012-07-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}